From the comparative study of the bioavailability of the preparation and efetinib mesylate in beagle dogs, it can be seen that the blood concentration Cmax and bioavailability of the preparation are lower than that of efetinib mesylate, and the bioavailability of the preparation is 56%.<br>
正在翻译中..